High incidence of disease recurrence in the brain and leptomeninges in patients with nonsmall cell lung carcinoma after response to gefitinib.
作者： Antonio M. P. Omuro , Mark G. Kris , Vincent A. Miller , Enrico Franceschi , Neelam Shah
DOI: 10.1002/CNCR.21033
关键词:
摘要: … We found a similar incidence and survival in our population composed almost exclusively of … disease. This suggests that improved local control may be associated with a high incidence …
sci-hub.se 参考文章(18)
Bruce Keith, Mark Vincent, Larry Stitt, Anna Tomiak, Richard Malthaner, Edward Yu, Pauline Truong, Richard Inculet, Michael Lefcoe, A. Rashid Dar, Walter Kocha, Ian Craig, Subsets more likely to benefit from surgery or prophylactic cranial irradiation after chemoradiation for localized non-small-cell lung cancer. American Journal of Clinical Oncology. ,vol. 25, pp. 583- 587 ,(2002) , 10.1097/00000421-200212000-00011
F. Andre, D. Grunenwald, J. L. Pujol, P. Girard, A. Dujon, L. Brouchet, P. Y. Brichon, V. Westeel, T. Le Chevalier, Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered? Cancer. ,vol. 91, pp. 2394- 2400 ,(2001) , 10.1002/1097-0142(20010615)91:12<2394::AID-CNCR1273>3.0.CO;2-6
Amy Law, Daniel D. Karp, Thomas Dipetrillo, Benedict T. Daly, Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma Cancer. ,vol. 92, pp. 160- 164 ,(2001) , 10.1002/1097-0142(20010701)92:1<160::AID-CNCR1304>3.0.CO;2-X
Giovanni Luca Ceresoli, Michele Reni, Giuseppe Chiesa, Angelo Carretta, Stefano Schipani, Paolo Passoni, Angelo Bolognesi, Piero Zannini, Eugenio Villa, Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer. ,vol. 95, pp. 605- 612 ,(2002) , 10.1002/CNCR.10687
James D. Cox, Raymond Yesner, William Mietlowski, Zbigniew Petrovich, Influence of cell type on failure pattern after irradiation for locally advanced carcinoma of the lung Cancer. ,vol. 44, pp. 94- 98 ,(1979) , 10.1002/1097-0142(197907)44:1<94::AID-CNCR2820440117>3.0.CO;2-O
Rose Lai, Chau T. Dang, Mark G. Malkin, Lauren E. Abrey, The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma Cancer. ,vol. 101, pp. 810- 816 ,(2004) , 10.1002/CNCR.20418
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Carlos A. Perez, Thomas F. Pajak, Philip Rubin, Joseph R. Simpson, Mohammed Mohiuddin, Luther W. Brady, Ruheri Perez-Tamayo, Marvin Rotman, Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group Cancer. ,vol. 59, pp. 1874- 1881 ,(1987) , 10.1002/1097-0142(19870601)59:11<1874::AID-CNCR2820591106>3.0.CO;2-Z
Vincent A. Miller, Mark G. Kris, Neelam Shah, Jyoti Patel, Christopher Azzoli, Jorge Gomez, Lee M. Krug, William Pao, Naiyer Rizvi, Barbara Pizzo, Leslie Tyson, Ennapadam Venkatraman, Leah Ben-Porat, Natalie Memoli, Maureen Zakowski, Valerie Rusch, Robert T. Heelan, Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 22, pp. 1103- 1109 ,(2004) , 10.1200/JCO.2004.08.158
Mark G. Kris, Ronald B. Natale, Roy S. Herbst, Thomas J. Lynch, Jr, Diane Prager, Chandra P. Belani, Joan H. Schiller, Karen Kelly, Harris Spiridonidis, Alan Sandler, Kathy S. Albain, David Cella, Michael K. Wolf, Steven D. Averbuch, Judith J. Ochs, Andrea C. Kay, Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients with Non-Small Cell Lung Cancer: A Randomized Trial JAMA. ,vol. 290, pp. 2149- 2158 ,(2003) , 10.1001/JAMA.290.16.2149